Stock Updates

Is Novo Nordisk A/S(NYSE: NVO), a large market cap stock a smart buy?

With a market cap of has a large market cap size. Novo Nordisk A/S (NYSE: NVO) has been on the stock market since its IPO date on the 1/4/1982. Novo Nordisk A/S is in the Drug Manufacturers – Other industry and Healthcare sector. Average volume for Novo Nordisk A/S, is 2477.31, and so far today it has a volume of 3849100. Performance year to date since the 1/4/1982 is -20.61%.

To help you determine whether Novo Nordisk A/S is undervalued the following values will help you decide. P/E is 21.09 and forward P/E is 18.36. PEG perhaps more useful shows that Novo Nordisk A/S has a value for PEG of 1.93. P/S ratio is 5.41 and the P/B ratio is 17.74. The P/Cash and P/Free cash flow is 39.19 and 28.97 respectively.

At the current price Novo Nordisk A/S is trading at, 44.88 (-1.51% today), Novo Nordisk A/S has a dividend yield of 3.14%, and this is covered by a payout ratio of 45.20%. Earnings per share (EPS) is 2.13, and this is looking to grow in the next year to 6.49% after growing 34.30% this past year. EPS growth quarter over quarter is 21.50%, and 1.50% for sales growth quarter over quarter.

The number of shares outstanding is 2001.27, and the number of shares float is 1356.68. The senior management bring insider ownership to 26.40%, and institutional ownership is at 10.00%. The float short is 0.15%, with the short ratio at a value of 0.83. Management has seen a return on assets of 41.50%, and also a return on investment of 85.00%.

The ability for Novo Nordisk A/S, to deal with debt, means it current ratio is 1.3, and quick ratio is 0.9. Long term debt/equity is 0 and total debt/equity is 0.01. In terms of margins, Novo Nordisk A/S has a gross margin of 84.80%, with its operating margin at 43.40%, and Novo Nordisk A/S has a profit margin of 32.70%.

The 52 week high is -21.85%, with 1.91% being its 52 week low. The 20 day simple moving average is -8.98% and the 200 day simple moving average is -14.60%.

Disclaimer: Remember there is a risk to your investment, this is not a recommendation, nor personal advice, never invest more than you are able too loose.


About the author

Mark Hines

Leave a Comment